{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:44:51Z","timestamp":1767422691630},"reference-count":57,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We have recently shown that a cocktail containing two leishmanial recombinant antigens (LmSTI1 and TSA) and interleukin-12 (IL-12) as an adjuvant induces solid protection in both a murine and a nonhuman primate model of cutaneous leishmaniasis. However, because IL-12 is difficult to prepare, is expensive, and does not have the stability required for a vaccine product, we have investigated the possibility of using DNA as an alternative means of inducing protective immunity. Here, we present evidence that the antigens TSA and LmSTI1 delivered in a plasmid DNA format either as single genes or in a tandem digene construct induce equally solid protection against<jats:italic>Leishmania major<\/jats:italic>infection in susceptible BALB\/c mice. Immunization of mice with either TSA DNA or LmSTI1 DNA induced specific CD4<jats:sup>+<\/jats:sup>-T-cell responses of the Th1 phenotype without a requirement for specific adjuvant. CD8 responses, as measured by cytotoxic-T-lymphocyte activity, were generated after immunization with TSA DNA but not LmSTI1 DNA. Interestingly, vaccination of mice with TSA DNA consistently induced protection to a much greater extent than LmSTI1 DNA, thus supporting the notion that CD8 responses might be an important accessory arm of the immune response for acquired resistance against leishmaniasis. Moreover, the protection induced by DNA immunization was specific for infection with<jats:italic>Leishmania<\/jats:italic>, i.e., the immunization had no effect on the course of infection of the mice challenged with an unrelated intracellular pathogen such as<jats:italic>Mycobacterium tuberculosis<\/jats:italic>. Conversely, immunization of BALB\/c mice with a plasmid DNA that is protective against challenge with<jats:italic>M. tuberculosis<\/jats:italic>had no effect on the course of infection of these mice with<jats:italic>L. major<\/jats:italic>. Together, these results indicate that the protection observed with the leishmanial DNA is mediated by acquired specific immune response rather than by the activation of nonspecific innate immune mechanisms. In addition, a plasmid DNA containing a fusion construct of the two genes was also tested. Similarly to the plasmids encoding individual proteins, the fusion construct induced both specific immune responses to the individual antigens and protection against challenge with<jats:italic>L. major<\/jats:italic>. These results confirm previous observations about the possibility of DNA immunization against leishmaniasis and lend support to the idea of using a single polygenic plasmid DNA construct to achieve polyspecific immune responses to several distinct parasite antigens.<\/jats:p>","DOI":"10.1128\/iai.70.6.2828-2836.2002","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:09:29Z","timestamp":1027764569000},"page":"2828-2836","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":76,"title":["Vaccination with Plasmid DNA Encoding TSA\/LmSTI1 Leishmanial Fusion Proteins Confers Protection against<i>Leishmania major<\/i>Infection in Susceptible BALB\/c Mice"],"prefix":"10.1128","volume":"70","author":[{"given":"A.","family":"Campos-Neto","sequence":"first","affiliation":[{"name":"Infectious Disease Research Institute"},{"name":"Medical School of Itajuba\u0301, Itajuba\u0301, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Webb","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Greeson","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. N.","family":"Coler","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. A. W.","family":"Skeiky","sequence":"additional","affiliation":[{"name":"Corixa Corporation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. G.","family":"Reed","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Institute"},{"name":"Corixa Corporation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02767767"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-308X(08)60152-9"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.161293498"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.4049\/jimmunol.160.5.2037","volume":"160","year":"1998","unstructured":"Campos-Neto, A., P. Ovendale, T. Bement, T. A. Koppi, W. C. Fanslow, M. A. Rossi, and M. R. Alderson. 1998. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J. Immunol.160:2037-2041.","journal-title":"J. Immunol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.6.4103-4108.2001"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.10.6227"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830241135"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.6.2614-2618.1994"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.2000.tb00008.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1515\/CCLM.1999.037","volume":"37","year":"1999","unstructured":"Deml, L., R. Schirmbeck, J. Reimann, H. Wolf, and R. Wagner. 1999. Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins. Clin. Chem. Lab. Med.37:199-204.","journal-title":"Clin. Chem. Lab. Med."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.617"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4049\/jimmunol.151.2.907","volume":"151","year":"1993","unstructured":"Evans, T. G., L. Thai, D. L. Granger, and J. B. Hibbs, Jr. 1993. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol.151:907-915.","journal-title":"J. Immunol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.4049\/jimmunol.163.7.3572","volume":"163","year":"1999","unstructured":"Faquim-Mauro, E. L., R. L. Coffman, I. A. Abrahamsohn, and M. S. Macedo. 1999. Cutting edge: mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. J. Immunol.163:3572-3576.","journal-title":"J. Immunol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.24.12013"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00398-4"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(94)00158-8"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.7.1137"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(00)00118-7"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00109-2"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/35047123"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.4049\/jimmunol.160.12.6004","volume":"160","year":"1998","unstructured":"Hirji, N., T. J. Lin, E. Bissonnette, M. Belosevic, and A. D. Befus. 1998. Mechanisms of macrophage stimulation through CD8: macrophage CD8\u03b1 and CD8\u03b2 induce nitric oxide production and associated killing of the parasite Leishmania major. J. Immunol.160:6004-6011.","journal-title":"J. Immunol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.4049\/jimmunol.160.9.4143","volume":"160","year":"1998","unstructured":"Huang, F. P., D. Xu, E. O. Esfandiari, W. Sands, X. Q. Wei, and F. Y. Liew. 1998. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production. J. Immunol.160:4143-4147.","journal-title":"J. Immunol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.8.3968-3970.1998"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.6.777"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00145-0"},{"key":"e_1_3_2_28_2","first-page":"15","volume":"3","year":"2001","unstructured":"Krieg, A. M., and H. L. Davis. 2001. Enhancing vaccines with immune stimulatory CpG DNA. Curr. Opin. Mol. Ther.3:15-24.","journal-title":"Curr. Opin. Mol. Ther."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(97)01145-1"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5371.1875"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830211216"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/22326"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.4049\/jimmunol.161.12.6532","volume":"161","year":"1998","unstructured":"Maecker, H. T., D. T. Umetsu, R. H. DeKruyff, and S. Levy. 1998. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. J. Immunol.161:6532-6536.","journal-title":"J. Immunol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30058-5"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s000110050580"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.11.5559-5566.1999"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5355-7_11"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.10.5595-5602.2000"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.8.5122"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830221206"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/108729199318183"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.4.741"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.4049\/jimmunol.163.3.1467","volume":"163","year":"1999","unstructured":"Piedrafita, D., D. Xu, D. Hunter, R. A. Harrison, and F. Y. Liew. 1999. Protective immune responses induced by vaccination with an expression genomic library of Leishmania major. J. Immunol.163:1467-1472.","journal-title":"J. Immunol."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5273.352"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1189\/jlb.68.6.793","volume":"68","year":"2000","unstructured":"Shedlock, D. J., and D. B. Weiner. 2000. DNA vaccination: antigen presentation and the induction of immunity. J. Leukoc. Biol.68:793-806.","journal-title":"J. Leukoc. Biol."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.12.7140"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.8.3719-3726.1999"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.3.783"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.160197797"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.7.3555"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.12.6970"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.13-1899"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7519(99)00112-5"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.7.3279-3289.1998"},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.4049\/jimmunol.157.11.5034","volume":"157","year":"1996","unstructured":"Webb, J. R., D. Kaufmann, A. Campos-Neto, and S. G. Reed. 1996. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. J. Immunol.157:5034-5041.","journal-title":"J. Immunol."},{"key":"e_1_3_2_57_2","first-page":"455","volume":"68","year":"2000","unstructured":"Weiner, G. J. 2000. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides. J. Leukoc. Biol.68:455-463.","journal-title":"J. Leukoc. Biol."},{"key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.160.8.3627","volume":"160","year":"1998","unstructured":"Zimmermann, S., O. Egeter, S. Hausmann, G. B. Lipford, M. Rocken, H. Wagner, and K. Heeg. 1998. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol.160:3627-3630.","journal-title":"J. Immunol."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.6.2828-2836.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.6.2828-2836.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T16:04:06Z","timestamp":1682265846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.70.6.2828-2836.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["10.1128\/IAI.70.6.2828-2836.2002"],"URL":"https:\/\/doi.org\/10.1128\/iai.70.6.2828-2836.2002","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]},"assertion":[{"value":"2001-11-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-03-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}